Clinical Trial Site — Washington D.C., District of Columbia

Clinical Trial Site is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Clinical Trial Site has participated in 22 clinical trials with 8 currently active.

Therapeutic areas: Atypical Hemolytic Uremic Syndrome, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, ANCA-Associated Vasculitis.

Sponsors: Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Amgen.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Trial Site?

Clinical Trial Site has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Trial Site conducted?

Clinical Trial Site has 22 clinical trials on record, with 8 currently active. Their work covers Atypical Hemolytic Uremic Syndrome, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, ANCA-Associated Vasculitis.

Is Clinical Trial Site accredited by Crixeo Health?

Yes — Clinical Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinical Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.